The cytidine deaminase AID (encoded by Aicda in mice and AICDA in humans) is critical for immunoglobulin class-switch recombination (CSR) and somatic hypermutation (SHM). Here we show that AID expression was induced by the HoxC4 homeodomain transcription factor, which bound to a highly conserved HoxC4-Oct site in the Aicda or AICDA promoter. This site functioned in synergy with a conserved binding site for the transcription factors Sp1, Sp3 and NF-jB. HoxC4 was 'preferentially' expressed in germinal center B cells and was upregulated by engagement of CD40 by CD154, as well as by lipopolysaccharide and interleukin 4. HoxC4 deficiency resulted in impaired CSR and SHM because of lower AID expression and not some other putative HoxC4-dependent activity. Enforced expression of AID in Hoxc4 -/-B cells fully restored CSR. Thus, HoxC4 directly activates the Aicda promoter, thereby inducing AID expression, CSR and SHM.
Class-switch recombination (CSR) and somatic hypermutation (SHM) are critical for the maturation of antibody responses to foreign and self antigens. CSR recombines switch-region DNA located upstream of exons of the constant heavy-chain (C H ) region, thereby altering immunoglobulin C H regions and endowing antibodies with new biological effector functions. SHM introduces mainly point mutations in immunoglobulin variable regions, thereby providing the structural substrate for the selection by antigen of antibody mutants with higher affinity. Despite advances in the identification of some factors involved in CSR and SHM, details of the mechanisms of these processes remain elusive. Both CSR and SHM require activation-induced cytidine deaminase (AID), which is expressed by activated B cells, mainly in germinal centers of peripheral lymphoid organs 1, 2 . AID initiates CSR and SHM by deaminating deoxycytosine residues to yield deoxyuracil-deoxyguanine mispairings in DNA [3] [4] [5] [6] [7] [8] . These mispairings trigger DNA-repair processes, which entails the introduction of mutations in variable-(diversity)-joining (V(D)J) regions or DNA breaks, including double-stranded DNA breaks, which lead to nonclassical nonhomologous end joining and CSR 3, 5, [9] [10] [11] [12] [13] [14] .
The mechanisms governing the transcriptional regulation of the gene encoding AID (AICDA in humans and Aicda in mice) remain to be elucidated. A conserved region in the first intron of Aicda containing two E-boxes, the consensus sequence for binding of the transcription factor E2A (A000804), has been suggested to contribute to the regulation of Aicda transcription through recruitment of the E2A helix-loop-helix transcription factor E47 and the inhibitor of DNA binding helix-loop-helix protein Id3, respectively 15 . The B cell lineagespecific transcription factor Pax5 is thought to act with E2A proteins in controlling Aicda transcription 16 . However, this was not confirmed by another study, which has instead suggested involvement of the Sp1 family of ubiquitous zinc-finger transcription factors. These regulate various promoters by binding to deoxyguanine-deoxycytosine, deoxyguanine-deoxyadenine or deoxyguanine-deoxythymine boxes in activating the Aicda promoter 17 .
Hox proteins are highly conserved helix-loop-helix homeodomaincontaining transcription factors that regulate cellular differentiation and organogenesis 18, 19 . Genes encoding these proteins, which are clustered chromosomally, are expressed in a temporally and spatially regulated way 20, 21 . Among the human genes, those encoding the HoxC proteins, particularly HOXC4, are expressed mainly in lymphoid cells 22 . HOXC4 expression increases through sequential stages of B cell development [22] [23] [24] [25] , from uncommitted hematopoietic progenitors in the bone marrow to mature B cells in the periphery, particularly when they are activated and proliferating. Malignant B cells, including those of mantle cell lymphoma, Burkitt's lymphoma and B cell chronic lymphocytic leukemia, have aberrant AID expression 26, 27 and abundant HoxC4 expression 22, 28 . HoxC4 induces the human 3¢ E a enhancer elements, particularly DNAse I-hypersensitive sites 1 and 2 (called 'hs1,2' here), in a B cell development stagespecific way 25 . HoxC4 binds to a HoxC4-Oct motif with the sequence 5¢-ATTTGCAT-3¢ in hs1, 2 (refs. 24,25) , which is conserved in humans, mice, rats and rabbits, and acts in synergy with homeodomain transcription factors Oct1 and Oct2 (A001704; collectively called 'Oct' here) and the Oca-B coactivator (A001696) to induce hs1,2 in B cells 24, 25 . HOXC4 expression is induced by stimuli that induce the differentiation of germinal center B cells and AICDA expression 24, 25 , such as CD154 (A000536) and interleukin 4 (IL-4; A001262), which suggests involvement of HoxC4 in CSR and SHM.
In this study, we test the hypothesis that HoxC4 regulates AID expression in human and mouse B cells. We show that HoxC4 bound to a HoxC4-Oct motif in the AICDA and Aicda promoters that is conserved in humans, chimps, mice, rats, dogs and cows. Binding of HoxC4 to this cis element activated the AICDA and Aicda promoters and induced AID expression, thereby inducing CSR and SHM. In this function, HoxC4 acted in synergy with an equally conserved upstream binding site for the transcription factors Sp1 and Sp3 (collectively called 'Sp' here) and NF-kB in the AICDA and Aicda promoters.
RESULTS

HoxC4 and AID are induced in germinal center B cells
HoxC4 is upregulated in human immunoglobulin D-negative (IgD -) CD38 + germinal center B cells 24, 25 , which express AID and undergo CSR and SHM. Stimulation of human IgD + CD38 -naive B cells with an agonistic monoclonal antibody (mAb) to CD40 and human IL-4 upregulates HoxC4 and induced AID expression 24, 25 . Here we further analyzed the expression of Hoxc4 and Aicda in the bone marrow, thymuses, spleens, Peyer's patches, livers and hearts of wild-type C57BL/6 mice. Real-time quantitative RT-PCR showed that like Aicda, Hoxc4 was expressed mainly in the spleen and Peyer's patches, which contain a large proportion of hypermutating and switching B cells but not in nonlymphoid organs such as the liver or heart (Fig. 1a) . To further address the correlation between the expression of HoxC4 and AID, we isolated PNA hi B220 + (germinal center) B cells and PNA lo B220 + (non-germinal center) B cells from the spleens of 8-to 10-week-old C57BL/6 mice 14 d after immunizing the mice with NP 16 -CGG (16 molecules of 4-hydroxy-3-nitrophenyl acetyl coupled to 1 molecule of chicken g-globulin) and measured HoxC4 and AID, as well as PCNA, a multifunctional protein critical for DNA replication and repair that has high expression in actively dividing cells. HoxC4 was specifically expressed in PNA hi B220 + germinal center B cells, which also had high expression of AID and PCNA (Fig. 1b) . Stimulation of mouse spleen B cells with bacterial lipopolysaccharide (LPS) and IL-4 or CD154 and IL-4, which induce the differentiation of germinal center B cells and Aicda expression, upregulated Hoxc4 expression by 10-to 15-fold (Fig. 1c) and induced CSR to IgG1 (data not shown), which indicates that HoxC4 is involved in inducing AID expression.
HoxC4 deficiency impairs the antibody response to NP-CGG We used Hoxc4 -/-mice to address the function of HoxC4 in CSR and SHM. Two laboratories independently generated two lines of HoxC4-deficient mice; homozygous mutants of both lines had esophageal defects and abnormal cervical and thoracic vertebral development and suffered high postnatal mortality rates 29, 30 . In these mice, the expression of Hoxc5 and Hoxc6, which are in the same gene cluster as Hoxc4, was lower, probably because of the effect of the neighboring neomycinresistance selection cassette inserted in the Hoxc4 locus 29, 30 . To obviate that effect, another laboratory generated a third Hoxc4 -/-strain in which the neomycin-resistance cassette was deleted by Cre recombinase through two flanking loxP sites in the germline ( Supplementary Fig. 1 online), thereby leaving the expression of Hoxc5 and Hoxc6 unaltered (A.M. Boulet and M.R. Capecchi, unpublished data). Those mice have since been lost, but frozen Hoxc4 +/-sperm on the C57BL/6 background was preserved. Using that Hoxc4 +/-sperm, we rederived Hoxc4 +/-mice by in vitro fertilization and bred them to obtain Hoxc4 -/-mice. These Hoxc4 -/-mice were born at the expected mendelian ratios, did not suffer the high postnatal mortality rate of the earlier HoxC4-deficient mouse lines 29, 30 and developed to adulthood.
In unimmunized Hoxc4 -/-mice, serum IgM titers were normal. However, the average serum IgG1 concentration was less than 0.6 mg/ml, compared with 1.2 mg/ml in their Hoxc4 +/+ littermates (data not shown), which suggested impairment of CSR. We immunized four pairs of 8-to 10-week-old littermate Hoxc4 -/-and Hoxc4 +/+ mice with NP 16 -CGG and analyzed blood from these mice for titers of IgM and IgG1; IgM and IgG1 bound to NP 30 ( (Fig. 2b,c) . Instead, it reflected the lower overall IgG1 and, together with the slightly lower NP 3 -binding IgM activity, a lower binding affinity for NP.
HoxC4 deficiency does not alter germinal center formation
The defective antibody response to NP-CGG in Hoxc4 -/-mice was not due to obvious defects in lymphoid differentiation. In these mice, the size of the spleen and the number and size of Peyer's patches were similar to those of Hoxc4 +/+ mice (data not shown). Moreover, the number of B cells and T cells, the proportion of CD4 + T cells, and the viability of B cells and T cells in the spleen and Peyer's patches, as analyzed by staining with 7-amino-actinomycin D, were also similar to those of Hoxc4 +/+ mice ( Fig. 3a-d ). After stimulation with LPS and IL-4, Hoxc4 -/-B lymphocytes were similar to Hoxc4 +/+ cells in terms of cell cycle, as analyzed by staining with propidium iodide, and cell division rate, as measured by incorporation of the vital dye CFSE (Fig. 3e,f) . In Hoxc4 -/-mice, the number and architecture of germinal centers in the spleen, the proportion of proliferating B cells, as shown by in vivo incorporation of the thymidine analog BrdU, as well as the proportion of PNA hi germinal center B cells in both spleen and Peyer's patches, were similar to those of Hoxc4 +/+ mice ( Fig. 3g-i 
e -C e and I a -C a in Hoxc4 -/-B cells stimulated for 3 d with LPS alone or LPS plus cytokines was similar to that in their Hoxc4 +/+ B cell counterparts ( Fig. 5 and Supplementary Fig. 3 online), whereas post-recombination I m -C H transcripts, which are generated by CSR, were significantly less abundant in Hoxc4 -/-B cells, by as much as 89.2%. Thus, HoxC4 deficiency impairs CSR to all isotypes without affecting germline I H -C H transcription.
To asses the effect of HoxC4 deficiency on SHM, we analyzed the IgH J H 4-intronic enhancer (iE m ) sequence downstream of rearranged V J558 DJ H 4 DNA in PNA hi B220 + germinal center B cells from Peyer's patches of 12-week-old unimmunized littermate Hoxc4 -/-and Hoxc4 +/+ mice. In these mice, the proportion of Peyer's patch PNA hi B220 + germinal center B cells was similar (Fig. 3h) . Analysis of 324 and 319 J H 4-iE m intronic DNA sequences (720 base pairs (bp)) from Hoxc4 -/-and Hoxc4 +/+ mice showed that Hoxc4 -/-mice had 59% fewer mutations (P o 0.00001; Fig. 6a ). The lower mutation frequency was associated with similarly fewer mutations of deoxyguanine-deoxycytosine and deoxyadenine-deoxythymine (Supplementary Fig. 4 online) and was not due to impaired transcription of the rearranged V J558 DJ H genes, as shown by specific real-time quantitative RT-PCR of Peyer's patch B cells from these Hoxc4 -/-mice and their Hoxc4 +/+ littermates (Fig. 6b) . Thus, HoxC4 deficiency substantially impairs SHM without altering the spectrum of the residual mutations or V H DJ H transcription. (Fig. 7a) . The lower abundance of Aicda transcripts was associated with much less AID protein (Fig. 7b) , which further suggests that HoxC4 regulates Aicda expression.
Binding of transcription factors to the Aicda promoter
To address the possibility that HoxC4 modulates Aicda expression by binding to a cis-regulatory element of this gene, we analyzed the sequence upstream of the putative transcription-initiation site of Aicda ( Supplementary Fig. 5 online). We identified eight motifs conserved in humans, chimps, mice, rats, dogs and cows (Supplementary Fig. 5 ). The first six motifs did not fulfill the minimal criteria for known transcription factor-binding sites by weightmatrix search with the Match program (threshold score, 0.75). The final two were a HoxC4-or Oct-binding site with a sequence of 5¢-ATTTGAAT-3¢ (residues -29 to -22 in humans and mice; scores, 1.0 for HoxC4 and 0.93 for Oct), which was nearly identical to the conserved HoxC4-Oct motif that is critical in inducing the human IGH 3¢ E a enhancer elements 24, 25 , and an upstream Sp-NF-kBbinding site with a sequence of 5¢-GGGGAGGAGCC-3¢ (residues -57 to -47 in humans and mice 17 ; scores, 0.93 for Sp1 and Sp3, and 0.96 for NF-kB). This sequence (5¢-GGGGAGGAGCC-3¢) has been suggested to be a Pax5-binding site 16 , but it did not satisfy, in our analysis, the minimum requirement for such a binding site (a score of 0.61). Both the putative HoxC4-Oct-binding site and the Sp-NF-kB-binding site were identical in all six species analyzed.
To determine the function of the region from position -349 to position -1 in the Aicda promoter (tentatively defined as the Aicda promoter on the basis of its high conservation) in the regulation of Aicda transcription, we constructed pGL3-luciferase reporter vectors consisting of the 349-bp Aicda promoter and/or the 490-bp flanking 5¢ region (Fig. 7c) upstream of the gene encoding the luciferase reporter, combined with nothing more or with conserved region1 (cr1) and/or cr2, which are in the first intron in the Aicda 15, 16 . We used these vectors to transfect human Ramos B cells, which spontaneously express AICDA and undergo SHM, and mouse CH12F3-2A B cells, which express Aicda and undergo CSR after stimulation with LPS, IL-4 and TGF-b1. We cultured these B cells and measured luciferase activity after 16 h (Ramos) or 24 h (CH12F3-2A). The construct that contained both the Aicda promoter and its flanking 5¢ region had 11-to 15-fold more activity than did the empty vector in Ramos and CH12F3-2A B cells (Fig. 7d) . Neither cr1 nor cr2 showed substantial enhancer activity in either Ramos or CH12F3-2A B cells. In addition, whereas the construct that contained only the Aicda promoter promoted transcription as efficiently as that containing both the Aicda promoter and its flanking 5¢ region, the construct that included only the flanking 5¢ region had only 'background' activity similar to that of empty vector in both Ramos B cells and stimulated CH12F3-2A B cells. These experiments show that the 349-bp Aicda promoter region had full promoter activity, whereas neither cr1 nor cr2 enhanced Aicda promoter activity in human or mouse B cells.
To address the specificity of the two evolutionarily conserved 5¢-ATTTGAAT-3¢ and 5¢-GGGGAGGAGCC-3¢ motifs, we did electrophoretic mobility-shift assay (EMSA) with wild-type and mutated oligonucleotide probes encompassing residues -65 to -14 of the human AICDA promoter sequence and containing both the HoxC4-Oct-binding site and the Sp-NF-kB-binding site (Sp-Hox), or an oligonucleotide probe encompassing residues -65 to -44 of the AICDA promoter sequence containing only the Sp-NF-kB-binding site (Sp; Supplementary Fig. 6a online) . Incubation of nuclear extracts of human 4B6 B cells, which spontaneously express AICDA and undergo CSR, or Ramos B cells, with the Sp-Hox probe gave rise to four main protein-DNA complexes: A and A¢, and B and B¢ ( Supplementary Fig. 6b,c) , specific for the binding of HoxC4-Oct and Sp-NF-kB, respectively. The mutated oligonucleotides Sp-Hox mut (in which the HoxC4-Oct-binding site was disrupted), Sp mut -Hox (in which the Sp-NF-kB-binding site was disrupted) and Sp mut -Hox mut (in which both sites were disrupted) did not efficiently achieve competition for the formation of complexes B and B¢, A and A¢, or all four complexes, respectively. We confirmed those results by EMSA with the mutated oligonucleotides as radiolabeled probes; Sp-Hox mut gave rise only to complexes B and B¢, Sp mut -Hox yielded only A and A¢, and Sp mut -Hox mut gave rise to none of the four complexes. Incubation of nuclear extracts of 4B6 or Ramos B cells with the Sp Supplementary Fig. 3 ). probe gave rise to three main protein-DNA complexes, C, C¢ and C¢¢, specific for the binding of Sp-NF-kB. We further confirmed the binding specificity of HoxC4, Oct1 and Oct2 to the 5¢-ATTTGAAT-3¢ site, and the binding specificity of Sp1, Sp3 and NF-kB to the 5¢-GGGGAGGAGCC-3¢ site, by supershift or inhibition of the formation of the respective protein-DNA complexes by using a specific mAb to HoxC4 and specific antibody to Oct1 (anti-Oct1), anti-Oct2, anti-Sp1, anti-Sp3 or antibody to the p52 subunit of NF-kB. No supershift or inhibition of protein-DNA complex involving the Sp-Hox or the Sp probe was achieved with a Pax5-specific antibody. These experiments show that HoxC4, Oct1 and Oct2 bind specifically to the conserved 5¢-ATTTGAAT-3¢ site in the AICDA promoter, whereas Sp1, Sp3 and NF-kB, but not Pax5, bind specifically to the conserved 5¢-GGGGAG GAGCC-3¢ site in the AICDA promoter.
Cis elements critical for Aicda and AICDA promoter activation To determine the contribution of the conserved cis elements, including HoxC4-Oct-and Sp-NF-kB-binding sites to the activity of the Aicda promoter, we constructed luciferase reporter vectors containing the mouse Aicda promoter sequence (residues -349 to -1) with mutation or deletion of the HoxC4-Oct-binding site and/or the Sp-NF-kB-binding site. In addition to the conserved HoxC4-Oct-binding site with the sequence 5¢-ATTTGAAT-3¢, we identified a putative HoxC4-binding site with a sequence of 5¢-ATTT-3¢ in the mouse and rat promoter (residues -155 to -158 of mouse Aicda) but not in the human, chimp or dog promoter ( Supplementary Fig. 5 ).
Deletion of this site did not alter the Aicda promoter activity (Fig. 8a) . In contrast, deletion of the Hoxc4-Oct motif resulted in promoter activity that was 71%, 64% and 88% lower in mouse CH12F3-2A B cells induced with LPS, IL-4 and TGF-b, in human 4B6 cells, and in Ramos B cells, respectively. To determine the relative contribution of the binding of HoxC4 and Oct to the promoter activity of the HoxC4-Oct motif as a whole, we mutated 5¢-ATTT-GAAT-3¢ to 5¢-CTTTGAAT-3¢, thereby disrupting the binding of HoxC4 but retaining the binding of Oct 25 , or to 5¢-ATTTGCCG-3¢, thereby abrogating the binding of Oct1-Oct2 but not of HoxC4 (mutated residues underlined) 25 . Mutation of the HoxC4 motif in the HoxC4-Oct site resulted in transcription that was 47%, 36% and 55% lower, whereas mutation of the Oct site resulted in transcription that was 28%, 21% and 55% lower, in CH12F3-2A, 4B6 and Ramos B cells, respectively. Thus, both the HoxC4 and Oct motifs of the HoxC4-Oct-binding site contribute to the Aicda promoter activity, as further confirmed by the up-to-88% loss of Aicda promoter activity when the entire Hoxc4-Oct-binding site was deleted. Further, mutation of the conserved Sp-NF-kB-binding site to 5¢-AAAAAGGAAA-3¢ resulted in promoter activity that was 73%, 80% and 63% lower in CH12F3-2A, 4B6 and Ramos B cells, respectively. In agreement with that result, deletion of this site resulted in promoter activity that was 85%, 68% and 82% lower in CH12F3-2A, 4B6 and Ramos B cells, respectively. Finally, deletion of the HoxC4-Oct-binding site combined with mutation or deletion of the Sp-NF-kB-binding site abrogated Aicda promoter activity. These experiments show that the conserved HoxC4-Oct-binding site is important to Aicda promoter activity and, together with the conserved Sp-NF-kB-binding site, is indispensable for full transcriptional activation of Aicda.
To confirm the relevance of our EMSA and luciferase reporter experiments, we precipitated chromatin from human 4B6 and Ramos B cells with anti-HoxC4, anti-Oct1, anti-Oct2, anti-Oca-B, anti-Sp1, anti-Sp3 or anti-NF-kB p52. In DNA precipitated by each antibody, we readily identified the AICDA promoter sequence (Fig. 8b,c) . The specificity of those findings was further proven by our ability to readily detect AICDA or Aicda promoter DNA in chromatin-immunoprecipitation assays involving human 2E2 B cells, which can be induced to express AID and undergo CSR after treatment with mAb to CD40 and cytokines (such as IL-4), mouse CH12F3-2A B cells, which can be induced to express AID and undergo CSR after treatment with LPS, IL-4 and TGF-b1, as well as spleen B cells from wild-type C57BL/6 mice activated by LPS plus IL-4 or by CD154 plus IL-4. Induction of CSR in 2E2 or CH12F3-2A B cells or primary mouse spleen B cells by these stimuli resulted in substantial Hoxc4 expression and recruitment of HoxC4, Oct1, Oct2, Oca-B, Sp1, Sp3 and NF-kB to the AICDA and Aicda promoters. Because it has been suggested that Pax5 is (indirectly) recruited to the Aicda promoter 16 , we precipitated chromatin in these human and mouse B cells with anti-Pax5; in these immunoprecipitated DNA complexes, we readily detected AICDA and Aicda promoter sequences, respectively. These findings show that HoxC4, Oct1, Oct2, Oca-B, Sp1, Sp3 and NF-kB are recruited to the AICDA and Aicda promoters in human and mouse B cells, respectively, that express AID and undergo CSR or SHM.
Enforced AID expression restores CSR in Hoxc4 -/-B cells
We then sought to demonstrate that the defective CSR in HoxC4-deficient B cells was actually due to impairment of AID expression and not some other HoxC4-dependent activity. For this, we enforced expression of AID in Hoxc4 -/-B cells to restore CSR. We used a control retroviral vector containing human IL2RA, which encodes the human IL-2 receptor (CD25; TAC), and an AID-expression retroviral construct containing human IL2RA and Aicda (TAC-Aicda) 15 (Supplementary Fig. 7 online) . We transduced LPS-activated spleen Hoxc4 +/+ and Hoxc4 -/-B cells with TAC and TAC-Aicda and stimulated them with LPS and IL-4 for 72 h and 96 h before analyzing CSR. Consistent with the results we obtained with untransduced Hoxc4 +/+ and Hoxc4 -/-B cells, CSR was much lower in Hoxc4 -/-B cells transduced with the TAC control retrovirus than in their Hoxc4 +/+ counterparts (Fig. 9a,b) . In 
DISCUSSION
In B cells, AID expression is tightly regulated [31] [32] [33] [34] , possibly in an activation-dependent way in conditions in which CSR and SHM unfold. The specificity and amount of AID expression are probably controlled by a complex combination of various tissue-specific transcription factors, both activators and repressors. Here we have provided evidence that by binding to the highly conserved 5¢-ATTT GAAT-3¢ motif in the Aicda promoter, HoxC4 activates this promoter, thereby modulating AID expression, CSR and SHM. In this function, HoxC4 acts in synergy with Oct1-Oct2, which also bind to the 5¢-ATTTGAAT-3¢ motif, by a mechanism similar to that reported for HoxC4-Oct-mediated activation of the human 3¢ E a hs1,2 enhancer element 25 . In agreement with that, Hoxc4 -/-mice or B cells show defective CSR and SHM despite normal expression of mature V H DJ H and germline I H -C H transcripts 31 . The full restoration of CSR by enforced expression of AID in Hoxc4 -/-B cells indicates that induction of AID is the main pathway through which HoxC4 regulates CSR and, probably, SHM. Mutation of the 5¢-ATTTGAAT-3¢ site to 5¢-GCTTGAATT-3¢, which does not disrupt the binding of Oct and introduces a putative Sp-binding site, does not seem to alter Aicda or AICDA promoter activity in mouse B lymphoma M12 and CH33 cells or human embryonic kidney 293 cells, respectively 16 . In our experiments, mutation of 5¢-ATTTGAAT-3¢ to disrupt HoxC4-binding activity while preserving the Oct-binding activity or to abrogate the binding of Oct1-Oct2 but not HoxC4 binding 25 resulted in less Aicda transcription, thereby emphasizing the function of these homeodomain transcription factors in AID expression and adding another dimension to the function of Oct1-Oct2 in B cell differentiation.
As we have shown in human B cells, HoxC4 serves an important and complex function in the regulation of the IgH locus 24, 25, 35 . The putative dampening effect of HoxC4 on the baseline activity of the I g and I e promoters would be effectively lifted and overridden by the strong activation of these promoters by CD40 signaling and CD154-induced HoxC4-mediated activation of the hs1,2 enhancer element 24, 25, 35 . The idea that HoxC4 is involved in the induction of AID expression is further strengthened by the demonstration that like AID, HoxC4 is expressed mainly in germinal center B cells of both humans 24 and mice (as reported here), and that engagement of CD40 by CD154 and treatment with cytokines, which induce the expression of AICDA and Aicda, also induces HOXC4 and Hoxc4 in human B cells 24 and mouse B cells (data presented here), respectively. Furthermore, NF-kB-binding sites in both the human and mouse HOXC4 and Hoxc4 promoters underpin the upregulation of HoxC4 by CD40 signaling (unpublished data).
Consistent with the idea that the defect in CSR and SHM manifested by Hoxc4 -/-B cells was due to a failure to induce Aicda expression, both Aicda transcripts and AID protein, as induced by LPS and IL-4 or CD154 and IL-4, were much less abundant in Hoxc4 -/-B cells. The tissue and differentiation-stage specificity of HoxC4 expression would account to a great extent for the precise regulation of AID expression. In Hoxc4 -/-mice, the lower AID expression was reflected in vivo in the impairment of the maturation of the T cell-dependent antibody response. In these mice, although Aicda expression was much lower, germinal center formation seemed normal. That phenotype is reminiscent of that of Aicda +/-mice 36 , which also have normal germinal centers in the presence of much lower Aicda expression 37, 38 , and contrasts with that of Aicda À/À mice, in which activated B cells accumulate and form giant germinal centers 36 . Pax5 has been suggested to serve a function in Aicda expression by binding to the 5¢-GGGGAGGAGCC-3¢ site in the Aicda promoter 16 . This cis element, however, does not fulfill the requirements of a consensus Pax5-binding motif and did not bind Pax5 in our experiments and those by others 17 . Our finding of a lack of specificity of the conserved 5¢-GGGGAGGAGCC-3¢ cis element for Pax5 suggests that recruitment of Pax5 to the Aicda promoter, as showed by chromatin-immunoprecipitation assay, occurred indirectly through other DNA-binding transcription factors, perhaps Sp1 or Sp3, by a mechanism similar to the interaction between the estrogen receptor and Sp1 on certain estrogen-responsive promoters 39 .
The B cell development-related transcription factor E47 has been suggested to contribute to the enhancement of Aicda promoter activity by binding to E-boxes in cr2 of the first intron of Aicda 21, 22 . E47-induced enhancement of Aicda promoter activity would be modulated by the E2A inhibitor Id3 (ref. 15) . The presence of cr2 in human Ramos B cells and mouse CH12F3-2A B cells (as reported here) and in mouse BaF/3 pro-B cells and M12 B cells 16 did not enhance transcription of the luciferase reporter driven by the Aicda promoter. This might reflect the dispensability of E2A transcription factors in the expression of AICDA and Aicda, CSR and, possibly, SHM, as shown by analysis of E2A-deficient B cells 40, 41 or the muted baseline activity of cr2 that resulted from 'preferential' binding of Id2 and/or Id3 to this region. These experiments, however, cannot rule out the possibility that like the IgH and immunoglobulin-k intronic enhancers, which contain many E-box sites and show a high enhancer activity in germinal center B cells 42 , cr2 and E proteins act together with HoxC4 to synergistically induce AID expression.
The HoxC4-mediated activation of the Aicda promoter was further enhanced by the upstream conserved 5¢-GGGGAG GAGCC-3¢ site, which, as we have also shown, recruited Sp1, Sp3 and NF-kB. Sp1 and Sp3 bind directly to DNA through their zincfinger motifs and enhance gene transcription. These proteins are ubiquitously expressed and are directly involved not only in the regulation of basal transcription and expression of 'housekeeping' genes but also in the expression of developmentally controlled genes. In our experiments, the Sp-NF-kB-binding site was able to partially mediate Aicda promoter activity in the absence of the HoxC4-Oct-binding site and possibly accounted for the residual AID expression, CSR and SHM in Hoxc4 -/-B cells and mice.
We have shown that Oca-B was also recruited to the AICDA and Aicda promoters in B cells undergoing CSR or SHM, probably through interaction with Oct1 and/or Oct2 (ref. 43) . By clamping together the POU H and POU S subdomains of Oct1 and Oct2, Oca-B would increase the affinity of these homeodomain proteins for DNA, thereby potentiating HoxC4-and Oct1-Oct2-mediated activation of the Aicda promoter. Oca-B is important in HoxC4-and Oct1-Oct2-mediated activation of the human 3¢ Ea enhancer hs1,2 element 25 . In agreement with that, mice that lack Oca-B have impaired CSR 43 . Our results here have identified another function for Oct1-Oct2 and Oca-B activity: regulating AID expression. Overall, our findings offer fundamental insights into the mechanisms of activation of the AICDA and Aicda promoters and induction of AID expression, CSR and SHM. The possibility that the induction of HoxC4 by stimuli other than CD40 signaling, LPS and cytokines, such as hormones (unpublished data), modulates AID expression and, therefore, antibody diversification in health and disease should be addressed.
METHODS
Hoxc4 -/-mice. In the Hoxc4 -/-mice used here (A.M. Boulet and M.R. Capecchi), Hoxc4 was disrupted through insertion of a loxP site in exon 2 of Hoxc4 at the sequence encoding the amino-terminal end (between the third and the fourth codons) of the homeobox, which introduces a stop codon at the insertion site and yields a nonfunctional truncated protein (lacking 95% of the homeodomain; unpublished observations). We obtained Hoxc4 +/-frozen sperm and rederived Hoxc4 +/-mice by in vitro fertilization through the services of the transgenic mouse facility of the University of California at Irvine. These Hoxc4 +/-mice were on a C57BL/6 background after backcrossing of the 129Sv/Ev founder strain with C57BL/6 mice. Hoxc4 -/-mice and their wildtype littermates were bred in pathogen-free conditions. The Institutional Animal Care and Use Committee of University of California at Irvine approved all animal experiments. B cell cycle and proliferation. Cell cycle was analyzed by staining with propidium iodide 50 . Proliferation was analyzed with the CellTrace CFSE Cell Proliferation kit (Molecular Probes). Cells were washed in serum-free Hank's balanced-salt solution (Invitrogen) and were resuspended at a density of 1 Â 10 6 cells per ml. After the addition of an equal volume of 2.4 mM CFSE (carboxyfluorescein succinimidyl ester), cells were incubated for 12 min at 37 1C and then were washed in FBS-RPMI. Cells were then diluted and were cultured in the presence or absence of LPS (20 mg/ml) from Escherichia coli (serotype 055:B5; Sigma-Aldrich) and recombinant mouse IL-4 (5 ng/ml; R&D Systems), then were collected at various times after activation and analyzed by flow cytometry. For in vivo B cell proliferation, mice were immunized with NP 16 -CGG. After 10 d, they were injected intraperitoneally twice within 16 h with 1 mg BrdU (5-bromodeoxyuridine) and were killed 4 h after the last injection. Cells from the spleen or Peyer's patches were stained with phycoerythrin-labeled mAb to mouse B220 (BD Biosciences) or that mAb together with FITC-labeled PNA. Incorporated BrdU was stained with allophycocyanin-labeled mAb to BrdU with the APC BrdU Flow kit (BD Biosciences) and were analyzed by flow cytometry.
